Ajinomoto and Eisai Company, Ltd. (ESALY.PK) Release: A Once-weekly Antiosteoporotic Agent 'Actonel(R) 17.5 mg Tablets' is Launched
6/19/2007 1:12:16 PM
Tokyo, June 15, 2007 (JCN Newswire) - Ajinomoto Co., Inc. and Eisai Co., Ltd. launched today a once-weekly antiosteoporotic agent 'Actonel(R) 17.5 mg tablets' - generic name: risedronate sodium hydrate - which was included in the NHI price list on June 8, 2007.
Ajinomoto owns the drug manufacturing approval of above product, and Eisai distributes the product supplied by Ajinomoto.
comments powered by